Novartis reported $4.54B in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Aphria Inc APH:CN C$ -353810000 214.73M
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Canopy Growth Corp WEED:CN C$ -19538000 412.39M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Johnson & Johnson JNJ:US $ 8058M 282M
Novartis NOVN:VX SF 4544M 120M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Zoetis ZTS:US $ 717M 11M